Dwight Dudley Koeberl

Dwight Koeberl practices at Duke University Hospital in Durham, North Carolina, part of Duke University.

Dwight Koeberl's NPI, 1023192184, was assigned on October 25, 2006. Dwight Koeberl graduated from Mayo Clinic Alix School of Medicine - Rochester in 1990. Dwight Koeberl holds North Carolina license 99-00275.

Dwight Koeberl's primary practice is Duke University Hospital, at 2301 Erwin Rd, Durham, NC 27705 in Durham County. The practice phone is (919) 684-8111.

Dwight Koeberl's primary practice is Duke University Hospital in Durham, North Carolina, part of Duke University. The medical group on file is Duke Health Integrated Practice. Dmand AI also links Dwight Koeberl to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dwight Koeberl practices, 2 sites in all. Vendor and product names are available with a free account.

Pediatrics is Dwight Koeberl's primary specialty in the NPI Registry, under taxonomy code 208000000X. Dwight Koeberl is board certified in clinical biochemical genetics by the American Board of Medical Genetics and Genomics. Dmand AI has Dwight Koeberl's licenses on file in 2 states: North Carolina and California.

CMS data shows 14 Medicare services from Dwight Koeberl across 1 procedure code in 2023, all of them office visits, for 15 Medicare patients. Medicare paid $1,331 for them. Every service was in an office.

CMS counts 15 Medicare patients who saw Dwight Koeberl in 2024. The largest group is 85 and over, with 0 patients. Their average risk score is 1.63, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dwight Koeberl's median patient age at 32, with 48% women.

In 2024, Dwight Koeberl wrote 52 Medicare Part D claims. 79% of them were for generic drugs. CMS names the drug for 45 of them, across 3 drugs with 11 or more claims each, at $898,909 in total drug cost. In 2023, CMS named 53 claims across 4 drugs.

Dwight Koeberl accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 129 papers to Dwight Koeberl, published from 2003 to 2025. 2019 was the busiest year, with 12. The most frequent topics are Genetic Therapy, Glycogen Storage Disease Type II and Glycogen Storage Disease Type I. Dwight Koeberl has published most often in Mol Genet Metab. Dwight Koeberl's most frequent co-authors are Priya S. Kishnani, Stephanie A. Austin, MD and Edward C. Smith, MD.

Dmand AI links Dwight Koeberl to 6 clinical trials, 3 of them phase 1/2 studies. 1 is still active or recruiting. Conditions studied include Glycogen Storage Disease Type II and Glycogen Storage Disease. Duke University sponsors the most, 4.

CMS Open Payments shows 29 general payments to Dwight Koeberl from 9 drug and device companies from 2016 to 2025. Acquisitions make up the largest share, 100% of the total. Bayer Healthcare Pharmaceuticals Inc. paid the most, $7,376,004.

Dmand AI lists 7 awards for Dwight Koeberl, most recently America's Best Doctors in 2009.

Dwight Koeberl graduated from Mayo Clinic Alix School of Medicine - Rochester in 1990. Dwight Koeberl is a member of AAP.

Dwight Koeberl is in network with 16 carriers, including Elevance, Aetna and United Healthcare. PPO plans come from the most carriers, 9. Check the plan with the practice before a visit.